Q1 2023 Holdings
Filed 2023-05-12 | 44 holdings | $202.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centene Corp del(CNC) | COM | 15135B101 | $27.4M | 432,834 | 13.5% |
| Cigna Group(CI) | COM | 125523100 | $22.3M | 87,175 | 11.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $20.6M | 967,347 | 10.2% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $20.5M | 128,164 | 10.1% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $16.8M | 75,003 | 8.3% |
| GE Healthcare Technologies Inc(GEHC) | COMMON STOCK | 36266G107 | $16.2M | 196,887 | 8.0% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $11.1M | 471,553 | 5.5% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $6.8M | 84,012 | 3.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $6.0M | 283,136 | 3.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $4.2M | 2,160,632 | 2.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.2M | 250,000 | 2.1% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $3.9M | 70,841 | 1.9% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $3.8M | 67,500 | 1.9% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $3.8M | 230,013 | 1.9% |
| Merrimack Pharmaceuticals Inc(MACKEUR) | COM NEW | 590328209 | $3.4M | 272,843 | 1.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.7M | 125,957 | 1.3% |
| Eucrates Biomedical Acquisition Corp. | UNIT 10/23/2027 | G3141W114 | $2.6M | 248,674 | 1.3% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $2.2M | 228,538 | 1.1% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $2.2M | 526,239 | 1.1% |
| Savara Inc(SVRA) | COM | 805111101 | $1.8M | 948,457 | 0.9% |
| Pharvaris NV(PHVS) | COM | N69605108 | $1.8M | 228,385 | 0.9% |
| Heska Corp(HSKAEUR) | COM RESTRC NEW | 42805E306 | $1.7M | 17,450 | 0.8% |
| Elevation Oncology Inc | COM | 28623U101 | $1.7M | 876,611 | 0.8% |
| Inogen Inc(INGN) | COM | 45780L104 | $1.5M | 121,535 | 0.7% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $1.4M | 188,875 | 0.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.3M | 347,869 | 0.7% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $1.2M | 280,000 | 0.6% |
| Corbus Pharmaceuticals Holdings(CRBP) | COM NEW | 21833P301 | $1.1M | 150,000 | 0.5% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $999.6K | 689,352 | 0.5% |
| Moleculin Biotech Inc | COM | 60855D200 | $970.5K | 1,010,956 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $961.1K | 70,000 | 0.5% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $927.6K | 246,036 | 0.5% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $871.4K | 3,004,959 | 0.4% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $840.6K | 123,797 | 0.4% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $732.0K | 254,150 | 0.4% |
| Neovasc Inc | COM | 64065J403 | $657.0K | 22,537 | 0.3% |
| Sientra Inc | COM | 82621J204 | $392.7K | 254,997 | 0.2% |
| Merus NV | COM | N5749R100 | $286.4K | 15,564 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $192.4K | 130,000 | 0.1% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $106.1K | 102,049 | 0.1% |
| Caremax Inc | COM CL A | 14171W103 | $82.1K | 30,741 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/2026 | 77313F114 | $65.4K | 400,000 | 0.0% |
| Humacyte Inc | *W EXP 08/27/2026 | 44486Q111 | $29.9K | 49,998 | 0.0% |
| Caremax Inc | *W EXP 06/08/2026 | 14171W111 | $5.7K | 12,808 | 0.0% |